Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer
Hlavní autoři: | Teoh, EJ, Bridges, EM, Morotti, M, Zois, CE, Lord, SR, Gleeson, FV, Harris, AL |
---|---|
Médium: | Conference item |
Jazyk: | English |
Vydáno: |
Springer
2017
|
Podobné jednotky
-
Fluciclovine (F-18) is a marker for high-affinity glutamine transporter ASCT2-mediated amino acid transport in breast cancer
Autor: Teoh, E, a další
Vydáno: (2017) -
Characterising ¹⁸F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging
Autor: Scott, NP, a další
Vydáno: (2021) -
Cancer imaging with fluciclovine (18F)
Autor: Teoh, E
Vydáno: (2018) -
Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer
Autor: Morotti, M, a další
Vydáno: (2020) -
Incidental Accumulation of Fluciclovine in Neuroendocrine Tumour in a Patient with Oncological Duplicity
Autor: Zuzana Balážová, a další
Vydáno: (2020-04-01)